Global Antifungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), Indication (Dermatophytosis, Aspergillosis, Candidiasis, Others), Dosage (Tablet, Ointment, Cream, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029,
Global Antifungal Drugs Market Analysis and Size
In recent years, the antifungal drugs market is anticipated to grow rapidly during the forecast period. Antifungal medications are used to treat fungal infections with the least amount of negative effects on the body. According to the Centers for Disease Control and Prevention (CDC), around 46,000 new cases of invasive candidiasis, a prevalent bloodstream infection in the United States, arise each year. The rate of fungal infections, such as Candida species, causing infection, varies significantly by geographic area and patient demographic, posing a challenge to healthcare providers. This led to the high demand for antifungal drugs in the market.
- Data Bridge Market Research analyses that the antifungal drugs market was valued at USD 13.1 billion in 2021 and is expected to reach USD 17.24 billion by 2029, registering a CAGR of 3.49% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Antifungal Drugs Market Definition
Antifungal drugs, often known as antimycotic drugs, are pharmaceuticals used to treat fungal infections of the skin, hair, and nails. Polyenes, azoles, and allylamines are some of the most regularly used antifungal medicines. They help cure athlete's foot, ringworm, aspergillosis, candidiasis, and fungal meningitis by neutralizing fungal agents and dermatophytes, including candida and tapeworms.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), Indication (Dermatophytosis, Aspergillosis, Candidiasis, Others), Dosage (Tablet, Ointment, Cream, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Gilead Sciences, Inc. (US), Apotex Inc. (Canada), Amneal Pharmaceuticals LLC. (US), Zydus Cadila (India), Aurobindo Pharma (India), Cipla Inc. (US), Hikma Pharmaceuticals PLC (UK), Dr. Reddy's Laboratories Ltd. (India), WOCKHARDT (India), Bausch Health Companies Inc. (Canada), Lannett (US), Torrent Pharmaceuticals Ltd. (India)
Antifungal Drugs Market Dynamics
- Rise in the incidences of fungal infections
The rising incidences of fungal and nosocomial infections are a primary driver of the growth of the antifungal drugs market. Antifungal agents are effective against systemic and superficial infections which are attained from exposure to contaminated surfaces in hospitals or humid conditions.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of antifungal drugs market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness myriad fungal infections will expand the antifungal drugs market. Additionally, high disposable income and increasing number of antifungal drugs as over-the-counter (OTC) will result in the expansion of antifungal drugs market. Along with this, rising geriatric population and rising consumption of antifungal drugs in developing regions for various medical conditions will enhance the market's growth rate.
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the antifungal drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. The rising focus of market players on launching generic products for treating fungal infections will further enhance the market's growth rate.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the antifungal drugs market during the forecast period.
Restraints/Challenges Global Antifungal Drugs Market
On the other hand, the high cost associated with the antifungal drugs will obstruct the growth rate of market. The increasing number of population with antifungal drug resistance and lack of healthcare infrastructure in developing economies will challenge the antifungal drugs market. Additionally, the availability of counterfeit drugs and side effects linked with antifungal drugs will restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This antifungal drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antifungal drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Antifungal drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Antifungal Drugs Market
Over the projected period, the antifungal drugs market is expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations have imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world are having difficulty continuing their supply chain activities. The antifungal drugs market has also been hampered by the supply chain slowness.
- In June 2021, Mankind Pharma had announced the launch of drug named Posaconazole Gastro. They are the resistant tablets which are used for the treatment of black fungus. It is found to be a safer as well as effective drug of choice for the management of disease. This drug had received approval from Drug Controller General of India (DCGI).
Global Antifungal Drugs Market Scope
The antifungal drugs market is segmented on the basis of drug class, indication, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
On the basis of drug class, the antifungal drugs market is segmented into azoles, echinocandins, polyenes, allylamines and others. Azoles are further segmented into imidazoles, thiazoles, voricanazole and others. Echinocandins are further segmented into micafungin, aspofungin, anidulafungin, and others. Polyenes are further segmented into amphotericin B, candicidin, hamycin, natamycin, and others. Allylamines are further segmented into terbinafine, butenafine and naftifine.
Based on indication, the antifungal drugs market is segmented into dermatophytosis, aspergillosis, candidiasis and others.
On the basis of dosage, the antifungal drugs market is segmented into tablet, ointment, cream, and others.
Route of Administration
The route of administration segment for the antifungal drugs market is segmented into oral, topical and others.
- Specialty Clinics
On the basis of end-users, the antifungal drugs market is segmented into hospitals, specialty clinics, homecare and others.
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
On the basis of distribution channel, the antifungal drugs market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Antifungal Drugs Market Regional Analysis/Insights
The antifungal drugs market is analysed and market size insights and trends are provided by country, drug class, indication, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the antifungal drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the antifungal drugs market because of the growing number of research and development activities and established framework of approval process in this region. Additionally, growing presence of major key players will further propel the market's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 202due to large number of generic manufacturers and rising government initiatives in this region. Also, development of healthcare infrastructure will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Antifungal Drugs Market Share Analysis
The antifungal drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antifungal drugs market.
Some of the major players operating in the antifungal drugs market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France), Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Gilead Sciences, Inc. (US)
- Apotex Inc. (Canada)
- Amneal Pharmaceuticals LLC. (US)
- Zydus Cadila (India)
- Aurobindo Pharma (India)
- Cipla Inc. (US)
- Hikma Pharmaceuticals PLC (UK)
- Dr. Reddy's Laboratories Ltd. (India)
- WOCKHARDT (India)
- Bausch Health Companies Inc. (Canada)
- Lannett (US)
- Torrent Pharmaceuticals Ltd. (India)